LAUREN LEEFLANG: Open Payments
NPI 1306393145 · FORT PIERCE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 33 payments from 6 companies in 2025. Trend: 2023 $678 · 2024 $1,116 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $328 |
| ViiV Healthcare Company | 15 | $256 |
| ABBVIE INC. | 3 | $77 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Lilly USA, LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $13 |
Products named: DOVATO, MAVYRET, APRETUDE, CABENUVA, ZERBAXA, MOUNJARO, Ozempic.
Industry payments across FL — which companies pay providers there.
